Abnormalities of B cell stimulatory factors (BSF) produced by T cells and B cell response to BSF from patients with systemic lupus erythematosus (SLE)

Jun Koide, Tohru Abe, Tsutomu Takeuchi, Osamu Hosono, Kouichi Amano, Mitsuo Homma

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

In the present study, we demonstrated that peripheral blood T lymphocytes from active patients with systemic lupus erythematosus (SLE) spontaneously produced B cell stimulatory factor (BSF) after 2 days’ culture. The BSF contained B cell growth factor (BCGF) and B cell differentiation factor (BCDF) activities. These BCGF and BCDF activities spontaneously produced by T cells from active SLE patients were almost as potent as that of PHA-stimulated T cells from normal individuals and inactive SLE patients. Furthermore, B lymphocytes from active patients with SLE proliferated or secreted IgG antibody in response to BCGF or BCDF alone in the absence of anti-IgM or SAC-stimulation. Particulary, B cells from active SLE patients produced marked IgG in response to BCDF. The activity of BCGF or BCDF spontaneously secreted by T cells from active SLE patients correlated inversely with the magnitude of responsiveness of B cells in response to BCGF or BCDF. Accordingly, the mechanism for B cell activation in patients with SLE seems to be heterogeneous. Such abnormal response to BSF and/or overproduction of BSF ultimately lead to polyclonal and even autoantigen-specific B cell expansion which result in the production of autoantibodies.

Original languageEnglish
Pages (from-to)208-215
Number of pages8
JournalJapanese Journal of Clinical Immunology
Volume7
Issue number4
DOIs
Publication statusPublished - 1984

Fingerprint

TCF Transcription Factors
Systemic Lupus Erythematosus
B-Lymphocytes
Interleukin-6
Intercellular Signaling Peptides and Proteins
T-Lymphocytes
Immunoglobulin G
Autoantigens
Autoantibodies
Antibody Formation

Keywords

  • B cell differentiation factor (BCDF)
  • B cell growth factor (BCGF)
  • B cell response
  • B cell stimulatory factor (BSF)
  • Systemic Lupus Erythematosus (SLE)

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Abnormalities of B cell stimulatory factors (BSF) produced by T cells and B cell response to BSF from patients with systemic lupus erythematosus (SLE). / Koide, Jun; Abe, Tohru; Takeuchi, Tsutomu; Hosono, Osamu; Amano, Kouichi; Homma, Mitsuo.

In: Japanese Journal of Clinical Immunology, Vol. 7, No. 4, 1984, p. 208-215.

Research output: Contribution to journalArticle

@article{9203857ef2214a9cb48889e1856d12d1,
title = "Abnormalities of B cell stimulatory factors (BSF) produced by T cells and B cell response to BSF from patients with systemic lupus erythematosus (SLE)",
abstract = "In the present study, we demonstrated that peripheral blood T lymphocytes from active patients with systemic lupus erythematosus (SLE) spontaneously produced B cell stimulatory factor (BSF) after 2 days’ culture. The BSF contained B cell growth factor (BCGF) and B cell differentiation factor (BCDF) activities. These BCGF and BCDF activities spontaneously produced by T cells from active SLE patients were almost as potent as that of PHA-stimulated T cells from normal individuals and inactive SLE patients. Furthermore, B lymphocytes from active patients with SLE proliferated or secreted IgG antibody in response to BCGF or BCDF alone in the absence of anti-IgM or SAC-stimulation. Particulary, B cells from active SLE patients produced marked IgG in response to BCDF. The activity of BCGF or BCDF spontaneously secreted by T cells from active SLE patients correlated inversely with the magnitude of responsiveness of B cells in response to BCGF or BCDF. Accordingly, the mechanism for B cell activation in patients with SLE seems to be heterogeneous. Such abnormal response to BSF and/or overproduction of BSF ultimately lead to polyclonal and even autoantigen-specific B cell expansion which result in the production of autoantibodies.",
keywords = "B cell differentiation factor (BCDF), B cell growth factor (BCGF), B cell response, B cell stimulatory factor (BSF), Systemic Lupus Erythematosus (SLE)",
author = "Jun Koide and Tohru Abe and Tsutomu Takeuchi and Osamu Hosono and Kouichi Amano and Mitsuo Homma",
year = "1984",
doi = "10.2177/jsci.7.208",
language = "English",
volume = "7",
pages = "208--215",
journal = "Immunological Medicine",
issn = "0911-4300",
publisher = "Taylor and Francis Ltd.",
number = "4",

}

TY - JOUR

T1 - Abnormalities of B cell stimulatory factors (BSF) produced by T cells and B cell response to BSF from patients with systemic lupus erythematosus (SLE)

AU - Koide, Jun

AU - Abe, Tohru

AU - Takeuchi, Tsutomu

AU - Hosono, Osamu

AU - Amano, Kouichi

AU - Homma, Mitsuo

PY - 1984

Y1 - 1984

N2 - In the present study, we demonstrated that peripheral blood T lymphocytes from active patients with systemic lupus erythematosus (SLE) spontaneously produced B cell stimulatory factor (BSF) after 2 days’ culture. The BSF contained B cell growth factor (BCGF) and B cell differentiation factor (BCDF) activities. These BCGF and BCDF activities spontaneously produced by T cells from active SLE patients were almost as potent as that of PHA-stimulated T cells from normal individuals and inactive SLE patients. Furthermore, B lymphocytes from active patients with SLE proliferated or secreted IgG antibody in response to BCGF or BCDF alone in the absence of anti-IgM or SAC-stimulation. Particulary, B cells from active SLE patients produced marked IgG in response to BCDF. The activity of BCGF or BCDF spontaneously secreted by T cells from active SLE patients correlated inversely with the magnitude of responsiveness of B cells in response to BCGF or BCDF. Accordingly, the mechanism for B cell activation in patients with SLE seems to be heterogeneous. Such abnormal response to BSF and/or overproduction of BSF ultimately lead to polyclonal and even autoantigen-specific B cell expansion which result in the production of autoantibodies.

AB - In the present study, we demonstrated that peripheral blood T lymphocytes from active patients with systemic lupus erythematosus (SLE) spontaneously produced B cell stimulatory factor (BSF) after 2 days’ culture. The BSF contained B cell growth factor (BCGF) and B cell differentiation factor (BCDF) activities. These BCGF and BCDF activities spontaneously produced by T cells from active SLE patients were almost as potent as that of PHA-stimulated T cells from normal individuals and inactive SLE patients. Furthermore, B lymphocytes from active patients with SLE proliferated or secreted IgG antibody in response to BCGF or BCDF alone in the absence of anti-IgM or SAC-stimulation. Particulary, B cells from active SLE patients produced marked IgG in response to BCDF. The activity of BCGF or BCDF spontaneously secreted by T cells from active SLE patients correlated inversely with the magnitude of responsiveness of B cells in response to BCGF or BCDF. Accordingly, the mechanism for B cell activation in patients with SLE seems to be heterogeneous. Such abnormal response to BSF and/or overproduction of BSF ultimately lead to polyclonal and even autoantigen-specific B cell expansion which result in the production of autoantibodies.

KW - B cell differentiation factor (BCDF)

KW - B cell growth factor (BCGF)

KW - B cell response

KW - B cell stimulatory factor (BSF)

KW - Systemic Lupus Erythematosus (SLE)

UR - http://www.scopus.com/inward/record.url?scp=85007760221&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85007760221&partnerID=8YFLogxK

U2 - 10.2177/jsci.7.208

DO - 10.2177/jsci.7.208

M3 - Article

VL - 7

SP - 208

EP - 215

JO - Immunological Medicine

JF - Immunological Medicine

SN - 0911-4300

IS - 4

ER -